122 related articles for article (PubMed ID: 25519708)
1. Costs of colorectal cancer in different states of the disease.
Färkkilä N; Torvinen S; Sintonen H; Saarto T; Järvinen H; Hänninen J; Taari K; Roine RP
Acta Oncol; 2015 Apr; 54(4):454-62. PubMed ID: 25519708
[TBL] [Abstract][Full Text] [Related]
2. Costs in different states of prostate cancer.
Torvinen S; Färkkilä N; Roine RP; Sintonen H; Saarto T; Taari K
Acta Oncol; 2016; 55(1):30-7. PubMed ID: 25833414
[TBL] [Abstract][Full Text] [Related]
3. Costs in Different States of Breast Cancer.
Roine E; Färkkilä N; Sintonen H; Taari K; Roine RP; Saarto T
Anticancer Res; 2019 Jan; 39(1):353-359. PubMed ID: 30591480
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in colorectal cancer.
Färkkilä N; Sintonen H; Saarto T; Järvinen H; Hänninen J; Taari K; Roine RP
Colorectal Dis; 2013 May; 15(5):e215-22. PubMed ID: 23351057
[TBL] [Abstract][Full Text] [Related]
5. Nonresectional management of colorectal cancer: multidisciplinary factors that influence treatment strategy.
Turner PS; Burke D; Finan PJ
Colorectal Dis; 2013; 15(10):e569-75. PubMed ID: 23751115
[TBL] [Abstract][Full Text] [Related]
6. Cost-effective management of colon and rectal cancer.
Heine JA; Rothenberger DA
World J Surg; 1991; 15(5):597-604. PubMed ID: 1949858
[TBL] [Abstract][Full Text] [Related]
7. Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK.
Guest JF; Ruiz FJ; Greener MJ; Trotman IF
Eur J Cancer Care (Engl); 2006 Mar; 15(1):65-73. PubMed ID: 16441679
[TBL] [Abstract][Full Text] [Related]
8. Assessing the economic value of anticancer therapies.
Neymark N
Recent Results Cancer Res; 1998; 148():1-285. PubMed ID: 9670279
[No Abstract] [Full Text] [Related]
9. The indirect costs of palliative care in end-stage cancer: A real-life longitudinal register- and questionnaire-based study.
Haltia O; Färkkilä N; Roine RP; Sintonen H; Taari K; Hänninen J; Lehto JT; Saarto T
Palliat Med; 2018 Feb; 32(2):493-499. PubMed ID: 28895471
[TBL] [Abstract][Full Text] [Related]
10. Resource utilization and cost analyses of home-based palliative care service provision: the Niagara West End-of-Life Shared-Care Project.
Klinger CA; Howell D; Marshall D; Zakus D; Brazil K; Deber RB
Palliat Med; 2013 Feb; 27(2):115-22. PubMed ID: 22249926
[TBL] [Abstract][Full Text] [Related]
11. Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003.
Walker H; Anderson M; Farahati F; Howell D; Librach SL; Husain A; Sussman J; Viola R; Sutradhar R; Barbera L
J Palliat Care; 2011; 27(2):79-88. PubMed ID: 21805942
[TBL] [Abstract][Full Text] [Related]
12. [Palliative chemotherapy in colorectal cancer--can we afford it?].
Kronborg O
Ugeskr Laeger; 1999 Jun; 161(25):3815. PubMed ID: 10412296
[No Abstract] [Full Text] [Related]
13. Time costs associated with informal care for colorectal cancer: an investigation of the impact of alternative valuation methods.
Hanly P; Céilleachair AÓ; Skally M; O'Leary E; Staines A; Kapur K; Fitzpatrick P; Sharp L
Appl Health Econ Health Policy; 2013 Jun; 11(3):193-203. PubMed ID: 23549793
[TBL] [Abstract][Full Text] [Related]
14. [The surgeon as a cost factor. Cost analysis exemplified by surgical treatment of rectal carcinoma].
Meyer T; Merkel S; Pfaffenberger M; Hohenberger W
Chirurg; 2002 Feb; 73(2):167-73. PubMed ID: 11974481
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy.
Abramson RG; Rosen MP; Perry LJ; Brophy DP; Raeburn SL; Stuart KE
Radiology; 2000 Aug; 216(2):485-91. PubMed ID: 10924575
[TBL] [Abstract][Full Text] [Related]
16. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.
Taplin SH; Barlow W; Urban N; Mandelson MT; Timlin DJ; Ichikawa L; Nefcy P
J Natl Cancer Inst; 1995 Mar; 87(6):417-26. PubMed ID: 7861461
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
18. The magnitude, share and determinants of unpaid care costs for home-based palliative care service provision in Toronto, Canada.
Chai H; Guerriere DN; Zagorski B; Coyte PC
Health Soc Care Community; 2014 Jan; 22(1):30-9. PubMed ID: 23758771
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT
Value Health; 2011; 14(5):647-51. PubMed ID: 21839401
[TBL] [Abstract][Full Text] [Related]
20. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
